Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
After a split, the index divisor is adjusted to maintain continuity. This explanation covers the reasons and how it impacts index levels.
25,578 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
Cerebras stock is catching attention this week as analysts initiate coverage and AI demand grows. This article breaks...
Is it time to broaden your exposure beyond the U.S.? This guide breaks down why international ETFs can fit into a 202...
A public clash over strategy and governance wrapped up for now, but 2026 could be a real test for lululemon. This inv...
A potential Dow reshuffle could end Nike's long run in the index and swap it for a consumer-facing giant. This articl...
By 2026, European DST policies are still pressing issues for tech giants and online platforms. This guide breaks down...
When a top investor steps up after a steep drop, it signals conviction. This deep dive looks at why First Beijing bou...
A looming base oil shortage threatens routine oil changes as global supply tightens. The ‘imminent’ crisis isn’t pump...
On Oct. 14, smart retirees take one afternoon to protect cash flow and simplify their finances. This guide lays out a...
When a high-profile TV season is shelved, the ripple effects go beyond the screen. This article breaks down the finan...
Investors woke up to a surge in Qualcomm stock after the company outlined bold AI-backed growth targets. This article...
In the first half of 2026, Sandisk towered over the S&P 500. This article explains the drivers behind that outperform...